KA

Kamalrani Ajmera

Director Director DIN 01545549
DIN 01545549 First appointment Jul 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2005
Shareholding value Locked Premium profile

About Kamalrani Ajmera

Data last updated:

Kamalrani Ajmera has 21 years in corporate governance. Formerly with 1 company, such as Bush Pharmacos Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 01545549
Primary Designation Director
First Appointment 15 Jul 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Bush Pharmacos Pvt Ltd U24232MP1988PTC004704
Director15 Jul 20051988Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bush Pharmacos Pvt Ltd
Premium access

Shareholding and investment profile for Kamalrani Ajmera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamalrani Ajmera

Kamalrani Ajmera has 21 years in corporate governance. Formerly with 1 company, such as Bush Pharmacos Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

Kamalrani Ajmera is associated with 0 companies as a director.

Kamalrani Ajmera has expertise in General Business.

Kamalrani Ajmera has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available